Female Infertility and IVF: Causes, Evaluation, and Treatment Planning

Medically reviewed on 10 April 2026 - Dr. Senai Aksoy
Female Infertility and IVF: Causes, Evaluation, and Treatment Planning

Key Takeaways

Female infertility is not one condition but a group of problems that can affect ovulation, the fallopian tubes, the uterus, ovarian reserve, or implantation. IVF can bypass some barriers, especially tubal disease, but the best treatment still depends on finding the main cause before treatment begins.

Female Infertility and IVF

Female infertility can result from ovulation disorders, tubal disease, endometriosis, uterine cavity problems, age-related decline in ovarian reserve, or a combination of factors. IVF is an important treatment option, but it is not the right first step for every patient. Good IVF planning starts with an accurate diagnosis.

Main Causes of Female Infertility

Female infertility is usually defined as the inability to conceive after 12 months of regular unprotected intercourse, or sooner when age or known risk factors justify earlier evaluation. The most common categories include:

Ovulation Disorders

Ovulation problems are a major cause of infertility. Common examples include PCOS, hypothalamic dysfunction, thyroid or prolactin disorders, and diminished ovarian function. Some of these problems respond well to simpler treatment before IVF is considered.

Tubal Disease

Blocked or damaged fallopian tubes can prevent egg pickup, fertilization, or normal embryo transport. Pelvic inflammatory disease, previous surgery, and endometriosis are common causes. This is one of the situations where IVF can be particularly useful because it bypasses the tube.

Uterine and Cervical Factors

Fibroids that distort the uterine cavity, endometrial polyps, adhesions, congenital uterine anomalies, and selected cervical problems can reduce the chance of implantation or increase miscarriage risk. Some of these issues are best corrected before IVF.

Age and Ovarian Reserve

Age affects both egg number and egg quality. As ovarian reserve and oocyte quality decline, the chance of natural conception falls and miscarriage risk rises. IVF may improve efficiency in this setting, but it cannot fully reverse age-related biology.

How Female Infertility Is Evaluated

Evaluation is usually based on the history, menstrual pattern, age, physical findings, and prior treatment. Common tests include:

Laparoscopy is not a routine screening test for every infertile patient, but it may be appropriate when endometriosis, pelvic adhesions, or another surgical diagnosis is strongly suspected.

When IVF Becomes the Right Option

IVF may be recommended when:

IVF can bypass the fallopian tubes and give more control over fertilization and embryo transfer timing. However, IVF outcomes are still shaped by age, embryo quality, uterine environment, and overall diagnosis.

FAQ

Does female infertility always mean IVF is needed?

No. Some causes respond to ovulation treatment, surgery, or timed lower-intensity treatment before IVF is considered.

When does IVF help the most?

IVF is especially useful when both tubes are blocked or severely damaged, when time matters because of age or ovarian reserve, or when several lower-intensity treatments have already failed.

Why is diagnosis still important if IVF is available?

Because IVF does not solve every barrier equally well. Uterine disease, hydrosalpinx, untreated endocrine problems, and embryo quality issues can still limit success if they are not recognized first.

Conclusion

Female infertility should be approached as a diagnostic problem before it becomes an IVF problem. IVF is highly effective in selected situations, especially tubal infertility, but the best results come from identifying the main barrier to pregnancy and choosing treatment accordingly.

Sources

Dr. Senai Aksoy

Dr. Senai Aksoy studied and trained in France before returning to Turkey, where he was a founding member of the ICSI team at Sevgi Hospital, Ankara — the country's first ICSI centre (1994-95) — and a co-author on the first Turkish ICSI publications produced in collaboration with the Brussels Van Steirteghem group (Human Reproduction, 1996; PMID 8671323). He helped build the IVF programme at the American Hospital Istanbul and has been running his own fertility practice since 1998.

Verified profiles: PubMed ORCID LinkedIn

The content has been created by Dr. Senai Aksoy and medically approved.